183 related articles for article (PubMed ID: 38232693)
1. Fc-fused IL-7 provides broad antiviral effects against respiratory virus infections through IL-17A-producing pulmonary innate-like T cells.
Kwon DI; Park S; Jeong YL; Kim YM; Min J; Lee C; Choi JA; Choi YH; Kong HJ; Choi Y; Baek S; Lee KJ; Kang YW; Jeong C; You G; Oh Y; Im SK; Song M; Kim JK; Chang J; Choi D; Lee SW
Cell Rep Med; 2024 Jan; 5(1):101362. PubMed ID: 38232693
[TBL] [Abstract][Full Text] [Related]
2. Hybrid Fc-fused interleukin-7 induces an inflamed tumor microenvironment and improves the efficacy of cancer immunotherapy.
Kim JH; Kim YM; Choi D; Jo SB; Park HW; Hong SW; Park S; Kim S; Moon S; You G; Kang YW; Park Y; Lee BH; Lee SW
Clin Transl Immunology; 2020; 9(9):e1168. PubMed ID: 32994996
[TBL] [Abstract][Full Text] [Related]
3. Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.
Kang MC; Choi DH; Choi YW; Park SJ; Namkoong H; Park KS; Ahn SS; Surh CD; Yoon SW; Kim DJ; Choi JA; Park Y; Sung YC; Lee SW
J Virol; 2015 Dec; 90(5):2273-84. PubMed ID: 26656713
[TBL] [Abstract][Full Text] [Related]
4. rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitors.
Lee M; Im SK; Baek S; Ji M; Kim M; Lee EJ; Ji ST; Ferrando-Martinez S; Wolfarth A; Lee JY; Kim D; Choi D
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38471713
[TBL] [Abstract][Full Text] [Related]
5. Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus.
Al-Beltagi S; Preda CA; Goulding LV; James J; Pu J; Skinner P; Jiang Z; Wang BL; Yang J; Banyard AC; Mellits KH; Gershkovich P; Hayes CJ; Nguyen-Van-Tam J; Brown IH; Liu J; Chang KC
Viruses; 2021 Feb; 13(2):. PubMed ID: 33546185
[TBL] [Abstract][Full Text] [Related]
6. Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity.
Rand U; Kupke SY; Shkarlet H; Hein MD; Hirsch T; Marichal-Gallardo P; Cicin-Sain L; Reichl U; Bruder D
Cells; 2021 Jul; 10(7):. PubMed ID: 34359926
[TBL] [Abstract][Full Text] [Related]
7. A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity.
Kim MY; Jayasinghe R; Devenport JM; Ritchey JK; Rettig MP; O'Neal J; Staser KW; Kennerly KM; Carter AJ; Gao F; Lee BH; Cooper ML; DiPersio JF
Nat Commun; 2022 Jun; 13(1):3296. PubMed ID: 35697686
[TBL] [Abstract][Full Text] [Related]
8. Respiratory Syncytial Virus Protects Bystander Cells against Influenza A Virus Infection by Triggering Secretion of Type I and Type III Interferons.
Czerkies M; Kochańczyk M; Korwek Z; Prus W; Lipniacki T
J Virol; 2022 Nov; 96(22):e0134122. PubMed ID: 36326278
[TBL] [Abstract][Full Text] [Related]
9. Compassionate use of recombinant human IL-7-hyFc as a salvage treatment for restoring lymphopenia in patients with recurrent glioblastoma.
Ahn S; Park JS; Kim H; Heo M; Sung YC; Jeun SS
Cancer Med; 2023 Mar; 12(6):6778-6787. PubMed ID: 36583472
[TBL] [Abstract][Full Text] [Related]
10. Pre-treatment with chicken IL-17A secreted by bioengineered LAB vector protects chicken embryo fibroblasts against Influenza Type A Virus (IAV) infection.
Lahiri A; Bhowmick S; Sharif S; Mallick AI
Mol Immunol; 2021 Dec; 140():106-119. PubMed ID: 34678620
[TBL] [Abstract][Full Text] [Related]
11. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
12. Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo.
Narayan R; Sharma M; Yadav R; Biji A; Khatun O; Kaur S; Kanojia A; Joy CM; Rajmani R; Sharma PR; Jeyasankar S; Rani P; Shandil RK; Narayanan S; Rao DC; Satchidanandam V; Das S; Agarwal R; Tripathi S
Cell Rep Med; 2023 Aug; 4(8):101127. PubMed ID: 37463584
[TBL] [Abstract][Full Text] [Related]
13. Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection.
Totura AL; Whitmore A; Agnihothram S; Schäfer A; Katze MG; Heise MT; Baric RS
mBio; 2015 May; 6(3):e00638-15. PubMed ID: 26015500
[TBL] [Abstract][Full Text] [Related]
14. Understanding the pharmacokinetic journey of Fc-fusion protein, rhIL-7-hyFc using complementary approach of two analytical methods, accelerator mass spectrometry and ELISA.
Kim A; Oh MS; Lee GH; Song S; Byun MS; Choi D; Yu BY; Lee H
Antib Ther; 2024 Apr; 7(2):105-113. PubMed ID: 38566969
[TBL] [Abstract][Full Text] [Related]
15. Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target.
Yuan S; Chu H; Huang J; Zhao X; Ye ZW; Lai PM; Wen L; Cai JP; Mo Y; Cao J; Liang R; Poon VK; Sze KH; Zhou J; To KK; Chen Z; Chen H; Jin DY; Chan JF; Yuen KY
Sci Adv; 2020 Aug; 6(35):eaba7910. PubMed ID: 32923629
[TBL] [Abstract][Full Text] [Related]
16. A defective viral genome strategy elicits broad protective immunity against respiratory viruses.
Xiao Y; Lidsky PV; Shirogane Y; Aviner R; Wu CT; Li W; Zheng W; Talbot D; Catching A; Doitsh G; Su W; Gekko CE; Nayak A; Ernst JD; Brodsky L; Brodsky E; Rousseau E; Capponi S; Bianco S; Nakamura R; Jackson PK; Frydman J; Andino R
Cell; 2021 Dec; 184(25):6037-6051.e14. PubMed ID: 34852237
[TBL] [Abstract][Full Text] [Related]
17. Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin.
Du X; Zuo X; Meng F; Han C; Ouyang W; Han Y; Gu Y; Zhao X; Xu F; Qin FX
Cell Prolif; 2021 Jan; 54(1):e12953. PubMed ID: 33211371
[TBL] [Abstract][Full Text] [Related]
18. A single administration of hIL-7-hyFc induces long-lasting T-cell expansion with maintained effector functions.
Kim S; Lee SW; Koh JY; Choi D; Heo M; Chung JY; Lee BH; Yang SH; Sung YC; Lee H; Shin EC; Park SH
Blood Adv; 2022 Dec; 6(23):6093-6107. PubMed ID: 36206199
[TBL] [Abstract][Full Text] [Related]
19. Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4
Kim EH; Nguyen TQ; Casel MAB; Rollon R; Kim SM; Kim YI; Yu KM; Jang SG; Yang J; Poo H; Jung JU; Choi YK
J Virol; 2022 Mar; 96(6):e0187321. PubMed ID: 35107382
[TBL] [Abstract][Full Text] [Related]
20. Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.
Li Q; Zhao Z; Zhou D; Chen Y; Hong W; Cao L; Yang J; Zhang Y; Shi W; Cao Z; Wu Y; Yan H; Li W
Peptides; 2011 Jul; 32(7):1518-25. PubMed ID: 21620914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
